These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2111784)

  • 1. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer.
    Pym B; Sandstad J; Seville P; Byth K; Middleton WR; Talley NJ; Piper DW
    Gastroenterology; 1990 Jul; 99(1):27-35. PubMed ID: 2111784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers. A placebo-controlled prospective study.
    Piper DW; Pym BM; Toy S; Gellatly R; Byth K; Seville P
    Med J Aust; 1986 Oct; 145(8):400-3. PubMed ID: 3093827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers.
    Tatsuta M; Iishi H; Okuda S
    Gut; 1986 Oct; 27(10):1213-8. PubMed ID: 3781336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of one gram daily cimetidine in the treatment of peptic ulcer in Singapore.
    Kang JY; Ng SK; Guan R
    Ann Acad Med Singap; 1983 Oct; 12(4):545-7. PubMed ID: 6678136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.
    Collen MJ; Hanan MR; Maher JA; Rent M; Stubrin SE; Arguello JF; Gardner L
    Dig Dis Sci; 1980 Oct; 25(10):744-9. PubMed ID: 7000474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
    Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
    Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has cimetidine revolutionised the medical treatment of peptic ulceration?
    Pounder RE
    J Hum Nutr; 1979 Oct; 33(5):367-70. PubMed ID: 501076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of cimetidine and trimipramine in the short-term treatment of duodenal and gastric ulcer.
    Valnes K; Wetterhus S; Myren J; Arva P; Larsen S
    Scand J Gastroenterol; 1983 Jan; 18(1):33-8. PubMed ID: 6372066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incompletely and completely healed duodenal ulcers' outcome in maintenance treatment: a double blind controlled study.
    Paoluzi P; Ricotta G; Ripoli F; Proietti F; Zaccardelli E; Carratù R; Torsoli A
    Gut; 1985 Oct; 26(10):1080-5. PubMed ID: 3902588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
    Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
    Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cimetidine in the treatment of peptic ulcer].
    Pera A; Lombardo L; Crivelli O; Verme G
    Minerva Med; 1977 Oct; 68(47):3277-82. PubMed ID: 335279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary methodology for controlled cost-benefit study of drug impact: the effect of cimetidine on days of work lost in a short-term trial in duodenal ulcer.
    Ricardo-Campbell R; Eisman MM; Wardell WM; Crossley R
    J Clin Gastroenterol; 1980 Mar; 2(1):37-41. PubMed ID: 6811651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of maintenance [correction of mentense] H2 blockers in peptic ulcer disease.
    Buchman AL
    Gastroenterology; 1991 Feb; 100(2):584-5. PubMed ID: 1985064
    [No Abstract]   [Full Text] [Related]  

  • 18. Cimetidine for severe gastroduodenal haemorrhage: a randomized controlled trial.
    Carstensen HE; Bülow S; Hansen OH; Jakobsen BH; Krarup T; Pedersen T; Raahave D; Svendsen LB; Backer O
    Scand J Gastroenterol; 1980; 15(1):103-5. PubMed ID: 6988936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study of cimetidine in patients with duodenal or gastric ulcer in Greece.
    Manousos ON; Zografos A; Nicolaou A; Scandalis N; Kalogerakou-Ioannidi E
    J Int Med Res; 1978; 6(5):381-3. PubMed ID: 700249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW
    Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.